CytRx Corporation's Reverse Merger Round

CytRx Corporation raised a round of funding on February 12, 2002. Investors include Global Genomics Capital.

CytRx Corporation (NASDAQ: CYTR), located in Los Angeles, California, is a biopharmaceutical research and development company specializing in oncology. CytRx currently is focused on the clinical devel…

Articles about CytRx Corporation's Reverse Merger Round: